April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Metabolic defects and oxidative stress in keratoconus
Author Affiliations & Notes
  • Dimitrios Karamichos
    Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK
  • Jesper Hjortdal
    Ophthalmology, Aarhus University Hospital, Aarhus C, Denmark
  • Audrey E K Hutcheon
    Ophthalmology, Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School, Boston, MA
  • John M Asara
    Division of Signal Transduction/Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
  • James D Zieske
    Ophthalmology, Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School, Boston, MA
  • Footnotes
    Commercial Relationships Dimitrios Karamichos, None; Jesper Hjortdal, None; Audrey Hutcheon, None; John Asara, None; James Zieske, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1001. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dimitrios Karamichos, Jesper Hjortdal, Audrey E K Hutcheon, John M Asara, James D Zieske; Metabolic defects and oxidative stress in keratoconus. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1001.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: Corneal bulging, stromal thinning and scarring are three of the main characteristics of the Keratoconus (KC) disorder. KC in most cases appears in early adulthood and can progress rapidly resulting in severe vision loss. Its prevalence ranges from 4-600/100,000 people worldwide. While efforts have been made over the years, the exact cause of the disease remains unknown. The aim of this study was to identify alterations in endogenous metabolites in the tears of KC patients depending on treatment.

Methods: 16 patients were included in this study and monitored using Pentacam tomography. Human tears were collected from healthy individuals and KC patients with different treatments. Three groups were tested: 1) Age-matched controls with no eye disease, 2) KC - No Correction, and 3) KC - Rigid Gas permeable lenses. All samples were processed for metabolomic analysis using LC-MS/MS.

Results: We evaluated 16 patients, 12 of which have been diagnosed with KC. Ages ranged between 20-53 y/o with maximum keratometric (Kmax) values of 44.9 - 63.7. We identified a total of 296 different metabolites of which >30 were significantly regulated between groups. The citric acid cycle included some of the affected metabolites that had notable changes, such as Fumarate, which had a ~4-fold upregulation in Group 2 and a 2-fold downregulation in Group 3 when compared to Healthy-No KC (Group 1). Also, Oxaloacetate had an ~2-fold downregulation in both Groups 2 and 3 when compared to Group 1. The oxidation state (redox) was also severely affected. Group 2 was under severe oxidative stress causing multiple metabolites to become upregulated when compared to the other Groups. Lactate and Arginine are just two of the significantly regulated metabolites related to redox. Lactate and Arginine levels were elevated 7 and 4 fold, respectively, in Group 2 compared to the others. Glutathione exists in both reduced (GSH) and oxidized (GSSG) states. A decreased GSH-to-GSSG ratio is considered indicative of oxidative stress; Group 2 showed 4-fold downregulation when compared to others, indicating significant oxidative stress levels.

Conclusions: Overall, our data supports the growing consensus that levels of metabolites are predictive for particular processes and conditions. These in vivo data showed clear links with our in vitro findings as well as indicating metabolism alterations in the tears of KC patients dependent on treatment.

Keywords: 574 keratoconus • 486 cornea: tears/tear film/dry eye • 592 metabolism  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.